Lung Cancer News

In a systematic review and meta-analysis, researchers found that the overall pooled lung cancer screening adherence rate among adults was 55%, “much lower” than rates reported in large randomized clinical trials.

The FDA granted fast track designation to irinotecan liposome injection for treatment of certain patients with small cell lung cancer, according to the agent’s manufacturer.

Tislelizumab prolonged OS compared with docetaxel for patients with advanced non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

On the third Thursday of each November, the American Cancer Society encourages the estimated 32.4 million smokers in the United States to begin the “journey to a smoke-free life” in the “Great American Smokeout.”

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, offered take home messages from a study focused on rheumatoid arthritis-associated interstitial lung disease, or RA-ILD, presented at ACR 2020.

The FDA granted priority review to cemiplimab-rwlc for treatment of certain patients with non-small cell lung cancer.

The FDA granted priority review to osimertinib for adjuvant treatment of certain patients with early-stage non-small cell lung cancer.

The addition of nivolumab to neoadjuvant chemotherapy significantly improved the pathologic complete response rate among patients with resectable non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

The FDA approved nivolumab in combination with ipilimumab for the treatment of adults with unresectable malignant pleural mesothelioma, the first drug regimen approved for this population in 16 years.

LUNGevity Foundation announced the recipients of its career development awards for lung cancer research.